Phibro shares soared nearly 18% after strong Q4 results beat estimates, driven by growth from the Zoetis MFA acquisition and solid full-year performance. Latest Ratings for PAHC Date Firm Action From To Jan 2022 Barclays Upgrades Underweight Equal-Weight Nov 2021 Morgan Stanley Initiates Coverage On Equal-Weight Jul 2021 Barclays Downgrades Equal-Weight Underweight View More Analyst Ratings for PAHC View the Latest Analyst Ratings read more